Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.48p
   
  • Change Today:
      0.005p
  • 52 Week High: 1.40
  • 52 Week Low: 0.39
  • Currency: UK Pounds
  • Shares Issued: 203.21m
  • Volume: 3,199,207
  • Market Cap: £0.97m
  • RiskGrade: 504
  • Beta: 0.02

Latest ShareCast News

Physiomics scores 'sizeable contract extension'

By Iain Gilbert

Date: Thursday 29 May 2025

(Sharecast News) - Data science and biostatistics company Physiomics said on Thursday that it has secured a "sizeable contract extension award" with an existing large pharmaceutical client.

Physiomics secures new contract with UK client

By Iain Gilbert

Date: Friday 09 May 2025

(Sharecast News) - Data science and biostatistics company Physiomics revealed on Friday that it has secured a contract award with a new UK client.

Physiomics project gets regulatory and ethical approval

By Josh White

Date: Wednesday 08 Jan 2025

(Sharecast News) - Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate UK-funded 'PREDICT-ONC' project had received both regulatory and ethical approval.

Physiomics announces new modelling and data scie... 04-Nov-2024 ShareCast
Physiomics secures new contract from existing ph... 17-Sep-2024 ShareCast
Physiomics secures new contract from existing ph... 17-Sep-2024 ShareCast
Physiomics re-engages with DoseMe for personalis... 14-Jun-2024 ShareCast
Physiomics wins new contract with existing client 13-Jun-2024 ShareCast
Physiomics lowers forecasts amid contract delays 03-May-2024 ShareCast
Physiomics secures 'substantial new contract' wi... 18-Mar-2024 ShareCast
Physiomics revenue rises, losses narrow in first... 07-Mar-2024 ShareCast
Physiomics secures contract with University of S... 19-Feb-2024 ShareCast
Physiomics awarded further contract by Numab The... 05-Feb-2024 ShareCast
Physiomics receives Innovate UK funding grant 10-Nov-2023 ShareCast
Physiomics inks contract extension with Numab Th... 08-Aug-2023 ShareCast
Physiomics inks collaboration deal with ValiRx s... 26-Apr-2023 ShareCast
Physiomics to present work at US cancer research... 14-Apr-2023 ShareCast
Physiomics wins further contract with Bicycle Th... 10-Mar-2023 ShareCast
Physiomics confident despite weaker first half 07-Mar-2023 ShareCast
Physiomics inks deal to work with Cancer Researc... 12-Oct-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Physiomics Market Data

Currency UK Pounds
Share Price 0.48p
Change Today 0.005p
% Change 1.06 %
52 Week High 1.40
52 Week Low 0.39
Volume 3,199,207
Shares Issued 203.21m
Market Cap £0.97m
Beta 0.02
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.62% below the market average27.62% below the market average27.62% below the market average27.62% below the market average27.62% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Price Trend
88.67% below the market average88.67% below the market average88.67% below the market average88.67% below the market average88.67% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average
Income Not Available
Growth
54.79% below the market average54.79% below the market average54.79% below the market average54.79% below the market average54.79% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

Physiomics Dividends

No dividends found

Trades for 06-Jun-2025

Time Volume / Share Price
12:49 25,663 @ 0.46p
11:52 40,767 @ 0.46p
11:43 150,000 @ 0.46p
11:43 345,562 @ 0.46p
11:32 60,021 @ 0.45p

Physiomics Key Personnel

CEO Peter Sargent

Top of Page